p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy

Overexpression of the ErbB2/HER2 receptor tyrosine kinase occurs in up to 20% of human breast cancers and correlates with aggressive disease. Several efficacious targeted therapies, including antibodies and kinase inhibitors, have been developed but the occurring of resistance to these agents is oft...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Bisaro, Brigitte, Sciortino, Marianna, Colombo, Shana, Leal, Maria Pilar Camacho, Costamagna, Andrea, Castellano, Isabella, Montemurro, Filippo, Rossi, Valentina, Valabrega, Giorgio, Turco, Emilia, Defilippi, Paola, Cabodi, Sara
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826217/
https://ncbi.nlm.nih.gov/pubmed/26716506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6710
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items